August 25, 2015 – On Wednesday, September 16, the Pediatric Advisory Committee (PAC) of the U.S. Food and Drug Administration (FDA) will meet to discuss pediatric-focused safety reviews, as mandated by The Food and Drug Administration Safety and Innovation Act (FDASIA) for several drugs. Included on the list of drugs to be reviewed is Exjade […]